Among the most prevalent molecular mechanisms involved in NSCLC to SCLC transformation, there are tumor protein p53 (TP53) mutations, retinoblastoma 1 (RB1) loss, lack of EGFR expression and MYC amplification [15]. The gene discussed is RB1; the disease is non-small cell lung carcinoma.